(Q48483797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Federico Turkheimer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Philip McGuire

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Oliver Howes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Elias Mouchlianitis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Philip Cowen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

L Rosso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

P Faulkner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J P Roiser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

5 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1254-1260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22665264%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mp.2012.78

3 February 2020

exact match

0 references

cites work

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

The dopaminergic basis of human behaviors: A review of molecular imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Differential effects of paroxetine on raphe and cortical 5-HT1A binding: a PET study in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Low-dose citalopram as a 5-HT neuroendocrine probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Multiresolution analysis of emission tomography images in the wavelet domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

The human raphe nuclei and the serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Ex vivo evaluation of the serotonin 1A receptor partial agonist [3H]CUMI-101 in awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

Neurochemical modulation of response inhibition and probabilistic learning in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

PET studies on the function of dopamine in health and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021

Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.78

7 January 2021